US Stock MarketDetailed Quotes

ZURA Zura Bio

Watchlist
  • 1.265
  • -0.090-6.64%
Close Mar 28 16:00 ET
  • 1.265
  • 0.0000.00%
Post 20:01 ET
86.49MMarket Cap-2.11P/E (TTM)

Zura Bio Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Assets
Current assets
Cash, cash equivalents and short term investments
76.84%176.5M
76.84%176.5M
81.23%188.22M
67.06%188.44M
104.30%89.82M
6,269.24%99.81M
2,014.53%99.81M
--103.86M
--112.8M
--43.96M
-Cash and cash equivalents
76.84%176.5M
76.84%176.5M
81.23%188.22M
67.06%188.44M
104.30%89.82M
6,269.24%99.81M
2,014.53%99.81M
--103.86M
--112.8M
--43.96M
Other current assets
116.59%2.25M
116.59%2.25M
2.86%754K
94.72%1.03M
55.69%657K
396.17%1.04M
--1.04M
--733K
--530K
--422K
Total current assets
77.25%178.74M
77.25%178.74M
80.68%188.98M
67.19%189.48M
103.84%90.47M
5,578.10%100.84M
2,036.50%100.84M
--104.59M
--113.33M
--44.39M
Non current assets
Net PPE
--91K
--91K
--44K
--25K
--9K
--0
--0
----
----
----
Non current deferred assets
----
----
----
----
----
----
----
--0
--0
--0
Other non current assets
--698K
--698K
--52K
----
----
----
----
----
----
----
Total non current assets
--789K
--789K
--96K
--25K
--9K
--0
--0
--0
--0
--0
Total assets
78.03%179.53M
78.03%179.53M
80.77%189.07M
67.21%189.5M
103.86%90.48M
1,816.44%100.84M
2,036.50%100.84M
--104.59M
--113.33M
--44.39M
Liabilities
Current liabilities
Payables
-73.34%733K
-73.34%733K
-2.86%1.6M
-85.96%990K
-38.36%1.49M
36.77%2.75M
--2.75M
--1.65M
--7.05M
--2.41M
-accounts payable
-73.34%733K
-73.34%733K
-38.36%1.01M
-85.96%990K
-38.36%1.49M
36.77%2.75M
--2.75M
--1.65M
--7.05M
--2.41M
-Total tax payable
----
----
--584K
----
----
----
----
----
----
----
Current accrued expenses
4.38%17.07M
4.38%17.07M
4.53%15.29M
1.85%12.55M
667.33%12.8M
618.14%16.35M
--16.35M
--14.62M
--12.32M
--1.67M
Current liabilities
-3.88%19.51M
-3.88%19.51M
7.24%18.24M
-24.41%15.07M
193.89%14.67M
37.01%20.3M
51,956.41%20.3M
--17.01M
--19.94M
--4.99M
Non current liabilities
Derivative product liabilities
--0
--0
--0
14.26%2.36M
3.84%1.6M
--990K
--990K
--1.95M
--2.07M
--1.54M
Preferred securities outside stock equity
----
----
----
----
----
----
----
--0
--0
--0
Total non current liabilities
--0
--0
--0
14.26%2.36M
3.84%1.6M
-92.08%990K
-92.08%990K
--1.95M
--2.07M
--1.54M
Total liabilities
-8.35%19.51M
-8.35%19.51M
-3.79%18.24M
-20.77%17.44M
149.16%16.27M
-22.06%21.29M
69.81%21.29M
--18.96M
--22.01M
--6.53M
Shareholders'equity
Share capital
75.00%7K
75.00%7K
75.00%7K
50.00%6K
33.33%4K
--4K
--4K
--4K
--4K
--3K
-common stock
75.00%7K
75.00%7K
75.00%7K
50.00%6K
33.33%4K
--4K
--4K
--4K
--4K
--3K
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-50.63%-155.9M
-50.63%-155.9M
-49.73%-142.27M
-40.14%-121.57M
-165.80%-111.24M
-222.85%-103.49M
-1,223.62%-103.49M
---95.02M
---86.75M
---41.85M
Paid-in capital
85.91%302.71M
85.91%302.71M
86.63%295.31M
78.66%278.09M
147.11%172.25M
--162.82M
--162.82M
--158.23M
--155.65M
--69.7M
Total stockholders'equity
147.45%146.82M
147.45%146.82M
142.11%153.05M
127.15%156.52M
119.02%61.01M
285.08%59.33M
858.79%59.33M
--63.21M
--68.91M
--27.86M
Noncontrolling interests
-34.70%13.2M
-34.70%13.2M
-20.68%17.78M
-30.67%15.54M
32.04%13.2M
102.21%20.22M
--20.22M
--22.42M
--22.42M
--10M
Total equity
101.15%160.02M
101.15%160.02M
99.49%170.83M
88.41%172.06M
96.05%74.21M
460.68%79.55M
1,117.41%79.55M
--85.63M
--91.32M
--37.86M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Assets
Current assets
Cash, cash equivalents and short term investments 76.84%176.5M76.84%176.5M81.23%188.22M67.06%188.44M104.30%89.82M6,269.24%99.81M2,014.53%99.81M--103.86M--112.8M--43.96M
-Cash and cash equivalents 76.84%176.5M76.84%176.5M81.23%188.22M67.06%188.44M104.30%89.82M6,269.24%99.81M2,014.53%99.81M--103.86M--112.8M--43.96M
Other current assets 116.59%2.25M116.59%2.25M2.86%754K94.72%1.03M55.69%657K396.17%1.04M--1.04M--733K--530K--422K
Total current assets 77.25%178.74M77.25%178.74M80.68%188.98M67.19%189.48M103.84%90.47M5,578.10%100.84M2,036.50%100.84M--104.59M--113.33M--44.39M
Non current assets
Net PPE --91K--91K--44K--25K--9K--0--0------------
Non current deferred assets ------------------------------0--0--0
Other non current assets --698K--698K--52K----------------------------
Total non current assets --789K--789K--96K--25K--9K--0--0--0--0--0
Total assets 78.03%179.53M78.03%179.53M80.77%189.07M67.21%189.5M103.86%90.48M1,816.44%100.84M2,036.50%100.84M--104.59M--113.33M--44.39M
Liabilities
Current liabilities
Payables -73.34%733K-73.34%733K-2.86%1.6M-85.96%990K-38.36%1.49M36.77%2.75M--2.75M--1.65M--7.05M--2.41M
-accounts payable -73.34%733K-73.34%733K-38.36%1.01M-85.96%990K-38.36%1.49M36.77%2.75M--2.75M--1.65M--7.05M--2.41M
-Total tax payable ----------584K----------------------------
Current accrued expenses 4.38%17.07M4.38%17.07M4.53%15.29M1.85%12.55M667.33%12.8M618.14%16.35M--16.35M--14.62M--12.32M--1.67M
Current liabilities -3.88%19.51M-3.88%19.51M7.24%18.24M-24.41%15.07M193.89%14.67M37.01%20.3M51,956.41%20.3M--17.01M--19.94M--4.99M
Non current liabilities
Derivative product liabilities --0--0--014.26%2.36M3.84%1.6M--990K--990K--1.95M--2.07M--1.54M
Preferred securities outside stock equity ------------------------------0--0--0
Total non current liabilities --0--0--014.26%2.36M3.84%1.6M-92.08%990K-92.08%990K--1.95M--2.07M--1.54M
Total liabilities -8.35%19.51M-8.35%19.51M-3.79%18.24M-20.77%17.44M149.16%16.27M-22.06%21.29M69.81%21.29M--18.96M--22.01M--6.53M
Shareholders'equity
Share capital 75.00%7K75.00%7K75.00%7K50.00%6K33.33%4K--4K--4K--4K--4K--3K
-common stock 75.00%7K75.00%7K75.00%7K50.00%6K33.33%4K--4K--4K--4K--4K--3K
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -50.63%-155.9M-50.63%-155.9M-49.73%-142.27M-40.14%-121.57M-165.80%-111.24M-222.85%-103.49M-1,223.62%-103.49M---95.02M---86.75M---41.85M
Paid-in capital 85.91%302.71M85.91%302.71M86.63%295.31M78.66%278.09M147.11%172.25M--162.82M--162.82M--158.23M--155.65M--69.7M
Total stockholders'equity 147.45%146.82M147.45%146.82M142.11%153.05M127.15%156.52M119.02%61.01M285.08%59.33M858.79%59.33M--63.21M--68.91M--27.86M
Noncontrolling interests -34.70%13.2M-34.70%13.2M-20.68%17.78M-30.67%15.54M32.04%13.2M102.21%20.22M--20.22M--22.42M--22.42M--10M
Total equity 101.15%160.02M101.15%160.02M99.49%170.83M88.41%172.06M96.05%74.21M460.68%79.55M1,117.41%79.55M--85.63M--91.32M--37.86M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Petroleo Brasileiro SA Petrobras
PBR
-0.07%
Vale SA
VALE
-1.28%
Ecopetrol
EC
-1.64%
Taylor Morrison Home
TMHC
-2.11%
KB Home
KBH
-2.50%

Unlock the Full List